z-logo
open-access-imgOpen Access
Tunicamycin Potentiates Antifungal Drug Tolerance via Aneuploidy in Candida albicans
Author(s) -
Feng Yang,
Vladimir Gritsenko,
Yaniv Slor Futterman,
Lu Gao,
Cheng Zhen,
Hui Lü,
Yuanying Jiang,
Judith Berman
Publication year - 2021
Publication title -
mbio
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.562
H-Index - 121
eISSN - 2161-2129
pISSN - 2150-7511
DOI - 10.1128/mbio.02272-21
Subject(s) - tunicamycin , caspofungin , biology , antifungal drug , unfolded protein response , candida albicans , echinocandin , microbiology and biotechnology , genetics , gene , amphotericin b , fluconazole , antifungal
How cells exposed to one stress are later able to better survive other types of stress is not well understood. In eukaryotic organisms, physiological and pathological stresses can disturb endoplasmic reticulum (ER) function, resulting in “ER stress.” Here, we found that exposure to tunicamycin, an inducer of ER stress, resulted in the acquisition of a specific aneuploidy, chromosome 2 trisomy (Chr2x3), in Candida albicans . Importantly, the resulting aneuploidy also conferred cross-tolerance to caspofungin, a first-line echinocandin antifungal, as well as to hydroxyurea, a common chemotherapeutic agent. Exposure to a range of tunicamycin concentrations induced similar ER stress responses. Extra copies of one Chr2 gene, MKK2 , affected both tunicamycin and caspofungin tolerance, while at least 3 genes on chromosome 2 ( ALG7 , RTA2 , and RTA3 ) affected only tunicamycin and not caspofungin responses. Other Chr2 genes ( RNR1 and RNR21 ) affected hydroxyurea tolerance but neither tunicamycin nor caspofungin tolerance. Deletion of components of the protein kinase C (PKC) or calcineurin pathways affected tolerance to both tunicamycin and caspofungin, supporting the idea that the ER stress response and echinocandin tolerance are regulated by overlapping stress response pathways. Thus, antifungal drug tolerance can arise rapidly via ER stress-induced aneuploidy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here